Position in HLN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$287,308
-$34,253 QoQ
Shares Held
30,794
-4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 182 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $7,361,298 across 10 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
54,538 | $2,857,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,216 | $1,200,695 | |
| 3 | VTRS |
Viatris Inc
|
56,808 | $902,111 | |
| 4 | ZTS |
Zoetis Inc.
|
9,027 | $648,680 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
3,838 | $646,856 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
17,060 | $295,308 | |
| 7 | HLN |
Haleon plc
This page
|
30,794 | $287,308 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
32,062 | $253,931 |
All Filings in HLN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,308 | 30,794 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $321,561 | 32,124 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $332,143 | 32,853 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $199,842 | 22,279 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $166,905 | 16,095 | Shares | Sole | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||